In this Issue
An App for That
How Smartphones Are Paving the Way for Improved Research and Care in Parkinson's Disease
With Ray Dorsey, MD, MBA
As the therapeutic landscape expands, an increasing range of options and a promising horizon will improve management of motor fluctuations for many patients with Parkinson’s disease.
By Laxman Bahroo, DO, Fahd Amjad, MD, Khashayar Dhastipour, MD, and Fernando Pagan, MD
Though it has been underutilized over the past two decades, deep brain stimulation is an effective intervention for many individuals with Parkinson’s disease.
With Mahlon DeLong, MD
Playing a critical role in Parkinson’s disease, LRRK2 offers a potential path toward better understanding and potentially treating the condition.
With Marco Baptista, PhD
Summary, significance, and the reasons why the SNIS published its own guidelines.
By Mahesh V. Jayaraman, MD
By Kevin G. Lazo, DO, Steven Mandel, MD, Bidyut Pramanik, MD, Jane Lee, MD, Maria V. Devita, MD, David Coven, MD, PhD, and Sandra Gelbard, MD
In today’s volatile tax environment, successful investment requires an emphasis on strategic after-tax asset growth.